Interpatient variability in bioavailability is related to the extent of absorption: implications for bioavailability and bioequivalence studies

Clin Pharmacol Ther. 1996 Dec;60(6):601-7. doi: 10.1016/S0009-9236(96)90208-8.

Authors

E T Hellriegel¹, T D Bjornsson, W W Hauck

Affiliation

¹ Department of Medicine, Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA 19107, USA.

PMID: 8988062
DOI: 10.1016/S0009-9236(96)90208-8

No abstract available

MeSH terms

Adult
Anti-Infective Agents / pharmacokinetics
Biological Availability*
Cardiovascular Agents / pharmacokinetics
Central Nervous System Agents / pharmacokinetics
Female
Humans
Male
Middle Aged
Therapeutic Equivalency*

Substances

Anti-Infective Agents
Cardiovascular Agents
Central Nervous System Agents